[Seroprevalence of anti-Mycoplasma pneumoniae antibodies in otherwise healthy children]

Rev Chil Pediatr. 2020 Jun;91(3):347-352. doi: 10.32641/rchped.v91i3.1476.
[Article in Spanish]

Abstract

Introduction: Mycoplasma pneumoniae (Mypn) infection could be occurring at an earlier age due to social pheno mena such as attending daycare centers more frequently and earlier than decades ago.

Objective: to estimate the prevalence of anti-Mypn antibodies in children aged 0-12 years, and to explore whether age, attendance to daycare center/school, overcrowding or the presence of children aged below 12 years in the households increase the risk of seropositivity.

Patients and method: Cross-sectional stu dy including healthy children aged 0-12 years which required blood draws for routine laboratory tests. In all cases, the aforementioned variables were recorded and anti-Mypn IgG was determined by enzyme immunoassay. The association between predictors and seropositivity was assessed in a logistic regression model.

Results: We included 232 patients (average age 56.4 ± 40.0 months). 56.9% attended a daycare center/school, 63.8% co-habited with children under 12 years old, and 15.9% lived in overcrowded households. The prevalence of anti-Mypn antibodies was 14.6%. There were no significant differences between seropositive and seronegative children regarding age (63.1 ± 40.7 vs. 55.4 ± 41.3 months), school/day-care attendance (64.7% vs. 55.5%), overcrowding (14.7% vs. 14.9%), or co-habiting with children (64.7% vs. 63.6%). Age was not an independent predictor of seropositivity in the multivariate model.

Conclusion: The prevalence of anti-Mypn antibodies in children was 14.6% and age was not a predictor of seropositivity.

MeSH terms

  • Antibodies, Bacterial / blood*
  • Argentina / epidemiology
  • Biomarkers / blood
  • Child
  • Child Day Care Centers
  • Child, Preschool
  • Cross-Sectional Studies
  • Crowding
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Logistic Models
  • Male
  • Mycoplasma pneumoniae / immunology*
  • Pneumonia, Mycoplasma / blood
  • Pneumonia, Mycoplasma / diagnosis
  • Pneumonia, Mycoplasma / epidemiology*
  • Prevalence
  • Risk Factors
  • Schools
  • Seroepidemiologic Studies

Substances

  • Antibodies, Bacterial
  • Biomarkers